Containing organic materials (A61L15/20)

Composition containing buffered lactic acid // 2628534
FIELD: pharmacology.SUBSTANCE: group of inventions refers to medicine, specifically to lubricating compositions containing buffered lactic acid with pH in the range of 3.0 to 6.5. The composition has an aqueous activity of 0.10 to 0.50 and the predetermined aqueous activity is obtained by drying.EFFECT: when the absorbent article contacts the skin or mucous membrane of the user, the friction between the absorbent article and the skin or mucosa decreases, the composition has a pH value in the range corresponding to acids that is close to the pH of skin or mucous membrane.13 cl, 9 dwg, 3 tbl, 1 ex
Haemostatic sponge and method for its preparation // 2618896
FIELD: pharmacology.SUBSTANCE: invention is a haemostatic sponge containing a base and an active substance, freeze-dried. According to the invention, the sponge, contains chitosan in acetic acid as the base and a fibrin monomer as the active substance, the components in the spongeare at a certain ratio in % by 1 litre volume.EFFECT: expansion of haemostatic sponges assortment based on a chitosan and fibrin-monomer complex with pronounced haemostatic action.4 cl, 13 ex

Protective product for wounds // 2615379
FIELD: pharmaceutics.SUBSTANCE: invention relates to pharmaceutics and represents use of protective article for wound dressing for microsurgical treatment of wounds, wherein protective product for healing contains buffer substance and wound pad, wherein wound pad contains hydrophilic polyurethane foam, buffer substances are present in foam and pH obtained at dilution of buffer substances in demineralized water at 37C of buffer solution ranges from pH 3 to pH 7. Invention provides reduction of microorganisms in wound and prevention of repeated contamination by microorganisms, which is provided by stabilizing pH value of liquid, absorbed in foam in acidic range, which ultimately allows to successfully increase interval of dressing changing. Besides result of application of protective article for wound dressing according to invention is easy separation of necrotic tissues from wound and removal of wound exudate, as well as reduced spreading of microorganisms in wound.EFFECT: application of protective product according to invention promotes especially effective microsurgical treatment of wounds.15 cl, 3 dwg, 2 tbl
Chitosan-based wound covering (versions) // 2613112
FIELD: pharmacy.SUBSTANCE: wound covering as a film, which contains chitosan, glycerol, cephalosporin or aminoglycoside antibiotics and a several acetic acid solution with concentration of 2% with the following component ratio, wt %: chitosan - 36-38, glycerin - 45-51, drug substance - 3-10, acetic acid - the rest. Cefotaxime sodium salt and cefazolin sodium salt are used as cephalosporin antibiotics, while amikacin sulfate and gentamicin sulfate are used as aminoglycoside antibiotics.EFFECT: coating provides antibacterial, wound-healing properties and prolonged action of the drug.4 cl; 1 ex
Hydrophilic gel for wound coating // 2589840
FIELD: medicine.SUBSTANCE: invention refers to medicine and can be used for closure and treatment of purulent wounds, burns and other skin damages. Described is hydrophilic gel for wound coating, which contains chitosan succinate, water and ethyl alcohol as auxiliary substances in following proportions, wt%: chitosan succinate-3-5, ethyl alcohol-8-16, water is balance.EFFECT: technical result is hydrophilic gel for wound coating with improved properties due to increased penetrating ability and healing and decontamination and preservation of shape on wound.1 cl, 3 ex
Wound dressing based on chitosan // 2582220
FIELD: medicine.SUBSTANCE: bandage for treatment of wounds in form of film containing chitosan, obtained from crusts of crabs, in form of salt of acetic acid, sulphates of alkali and alkali-earth metals as cross-linking agent, acetic acid and antibacterial preparations, with following ratio of components, wt%: Chitosan 65-70, antibacterial preparations 2-14, cross-linking agent 10-15, acetic acid is balance. As antibacterial preparations bandage comprises cephalosporin antibiotics, and cross-linking agent - sulphates of alkali and alkali-earth metals.EFFECT: dressing represents elastic, insoluble in water film not containing toxic substances, having good adsorbing, antibacterial and wound-healing properties, as well as capable of long-term output of drug preparation.3 cl, 1 ex

Agent for treatment of nonwoven and textile fabric // 2571144
FIELD: textile, paper.SUBSTANCE: nonwoven fabric contains the thermal bonded fibre to which the agent for fibre processing is glued. The agent for treatment of fibre contains polyorganosiloxane, complex alkyl phosphate ether and anion surfactant presented by the formula.EFFECT: optimisation of the process of fabrication of nonwoven fabric for absorbing products.17 cl, 9 dwg, 7 tbl

Adhesive composition for soft tissues, adhesive composition for wound management or composition for wound dressing // 2538677
FIELD: medicine.SUBSTANCE: there are described an adhesive composition for soft tissues, an adhesive composition for wound management or a composition for wound dressing containing a monomer (A), a polymer (B) and a polymerisation inducing composition (C) containing a organoboron compound and having a viscosity of 0.4 to 75000 cP within 30 seconds after mixing the ingredients (A), (B) and (C).EFFECT: composition possess low toxicity, low hazard and high adhesive strength, as well as excellent processing characteristics when applying and able to form a film possessing the unique properties.16 cl, 3 dwg, 16 tbl

Composition for hard tissue repair // 2537130
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to medicine. What is described is a composition for hard tissue repair containing 5 to 98.95 weight portions of a monomer (A), 1 to 75 weight portions of (meth)acrylate polymer (B) and 0.05 to 20 weight portions of a polymerisation initiating composition (C) containing an organoboron compound (c1) providing the ingredients (A), (B) and (C) total makes 100 weight portions. What is described is a kit for the hard tissue repair.EFFECT: composition generates little setting heat and can provide for manipulations for a long period of time.18 cl, 2 dwg, 11 tbl

Biodegradable wound coating and method for preparing biodegradable wound coating // 2519158
FIELD: medicine.SUBSTANCE: what is described is a coating in the form of a film which contains the following ingredients, wt %: low-molecular edible chitosan 5.3-5.7, glycerol 2.2-2.8, ceruloplasmin 0.06-0.08, L-asparaginic acid 0.04-0.06, a solvent with pH 5-7 - the rest. What is described is a method for preparing the coating consisting in the fact that a chitosan weigh is diluted in the solvent at 1000 mg of the weigh to 15 ml of the solvent, mixed and placed in a thermostat at a temperature of 37-42C for 1-2 hours. The mixture is added with ceruloplasmin diluted in the solvent at 1:10 to form a homogenous hydrogel. L-asparaginic acid is diluted in the solvent pre-heated to 37-40C and added to the mixture to provide pH of the mixture 5-7. A plasticising agent in the form of glycerol is added in the amount of 2.2-2.8% of total volume of the prepared biomass The prepared biomass is placed into containers to form a uniform layer of the coating 3-5 mm high and to form a film by drying the biomass for 18-24 hours in the thermostat at a temperature of 37-40C.EFFECT: wound coating provides the highest clinical effect.6 cl, 6 dwg, 2 ex
Tampon coating with fatty acid esters and effectiveness of toxin inhibition // 2518235
FIELD: medicine.SUBSTANCE: invention refers to medicine. What is described is using active ingredients as exemplified by GML (Glycerol Monolaurate) on a fibrous absorbent structure, such as viscose fibre, used for tampons production, in the very low concentrations enables maintaining effectiveness on the inhibition of synthesis of a toxic shock syndrome toxin 1 (TSST-1) produced by S.aureus, without evident microorganism elimination for the purpose of achieving the desired reduction of the toxin concentration and avoiding undesired impurities.EFFECT: achieving the desired reduction of the toxin concentration and avoiding undesired impurities.16 cl, 6 tbl, 3 ex

Absorbent products containing odour control system // 2505319
FIELD: medicine.SUBSTANCE: what is described is an absorbent product comprising an odour control material containing at least one inclusion complex of cyclodextrine and an organic compound dispersed in a matrix containing polysiloxane oil.EFFECT: absorbent product containing the inclusion complex of cyclodextrine and the organic compound in the form that can be easily included in such products and moisture-protected.9 cl, 1 dwg, 3 ex
Antimicrobial composition // 2500394
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to medicine. An antimicrobial composition contains chlorhexidine and pentane-1,5-diol, wherein the amount of chlorhexidine makes 0.000001 to 5 wt %, while the amount of pentane-1,5-diol makes 1 to 75 wt %. The composition is applicable for local administration; it contains a carrier and a gelling material.EFFECT: group of inventions enables applying the composition for non-therapeutic disinfection, in treating skin infections.
Corn plaster // 2454249
FIELD: medicine.SUBSTANCE: invention refers to medical and chemical-pharmaceutical industry and is applicable in healthcare facilities and domiciliary for external application as a remedy in skin diseases: corns, plantar callosities, callules. A corn plaster contains salicylic acid, precipitated sulphur, anhydrous lanolin, pine rosin, lump rubber, dimethylsulphoxide, pine resion, petrolatum and agidol with salicylic acid used as micronised particles sized max. 30 mcm, and the ingredients taken in certain proportions. The experimental clinical findings have shown that the leukocytic mass applied on corns has an effect on adjoining skin areas causing no allergy, irritation or redness if the plaster is applied on healthy skin.EFFECT: corn plaster improves keratolytic, antiseptic and antimycotic properties ensured by qualitative and quantitative composition of the ingredients.

Sustained-action bandage // 2432177
FIELD: medicine.SUBSTANCE: invention refers to medicine, more specifically to dressing used for closure and treatment of burns, wounds of various aetiology, trophic ulcers, decubitus ulcers, etc. What is described is a bandage in which three components are used: a wound-facing nontraumatic textile layer with antiseptic butole in the concentration 0.05 mg/cm2 to 1.0 mg/cm2 in a therapeutic layer which is coated with a replaceable sorptive layer made of a nonwoven fabric and providing sorption power of the bandage within 15 g/g and 10 g/g once changed. The replaceable sorptive layer is fixed between the therapeutic and sorptive layers by means of an adhesive frame which is a third component, e.g. made of a nonwoven fabric 0.1-0.5 mm thick and 6.0-10.0 mm wide; both surfaces of the frame are coated with a therapeutic adhesive, and an outer size of the framework is equal to a length and a width of the therapeutic layer. The therapeutic layer additionally contains drugs of haemostatic, anaesthetising, antioxidant and/or wound healing action.EFFECT: production of the sustained-action bandage with extended spectrum of antimicrobial action, improved antimicrobial activity and higher sorption power.2 cl, 1 tbl

Haemostatic plaster // 2417076
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine, namely to local haemostatic bandaging materials, and can be used in medical and preventive health care facilities. A haemostatic plaster contains a bottom layer of two design versions oriented to contact skin of various sensitivity: supersensitive skin requires thermomelting hypoallergenic non-continuous glue, while skin of moderate sensitivity, a glue of the following composition is used: lump rubber - 12.85 %, synthetic rubber - 12.85 %, pine rosin - 20.35 %, lanolin - 9.9 %, zinc oxide - 32 %, medical mineral oil - 11.3 %, antioxidant additive Agidol - 0.75 %, and a water-absorbing pad fixed on an adhesive layer, made of a nonwoven fabric and impregnated with a haemostatic compound of the following proportions: sodium carboxymethyl cellulose - 0.25-0.4 mg/cm2; calcium chloride - 1.3-1.4 mg/cm2, Furacilin - 0.003-0.005 mg/cm2. The adhesive layer coats the bottom layer either continuously, or in parallel stripes.EFFECT: provided higher haemostatic properties of the plaster and reduced injures of the patient's skin with pain hypersensitivity threshold.2 cl, 4 dwg, 2 ex
ethod of preparation of extensive difficult-to-heal wounds to dermanaplasty // 2404817
FIELD: medicine.SUBSTANCE: invention relates to medicine, more specifically the preparation of extensive long-term non-healing wounds to dermanaplasty requiring the use of plastic split-skin graft. The method consists of applying hemostatic dressings are applied Gemoteks on the wound for 2-3 minutes immediately after surgical treatment on the, in the first stage of wound healing process dressings are used (3-4 days) with the alternation of Atraumatic Tissue Activetex HL, Activetex HF and Activetex HVIT-complex, while on the second stage of wound healing process (2-3 days) tissues Activetex FOM and Activetex FHF are alternated. After the appearance of the boundary epithelialisation and wound cleansing free skin grafting with split-skin graft is performed in accordance with traditional techniques.EFFECT: invention solves the problem of easier and cheaper method of treatment of extensive long-term non-healing wounds by reducing the time of preparation of the wound surface to dermanaplasty.2 tbl

Wound bandage including protein polymer and polyfunctional spacer // 2349347
FIELD: medicine.SUBSTANCE: method of obtaining wound bandage material is claimed. Method involves obtaining protein polymer by protein reaction with polyfunctional spacer or its activated derivative. Preferred polyfunctional spacer is polycarboxylic acid, especially dicarboxylic acid. Protein polymers obtained with such spacers can be applied in a wide range of therapeutic purposes, including wound bandage materials, therapeutic agent delivery to organism, and bioadhesive and sealing substances.EFFECT: obtaining material taking exact shape of wound filling wound hollow completely without irritation of exposable tissues.27 cl, 2 dwg, 13 tbl, 12 ex
Self-locking bandage // 2323009
FIELD: medical articles, in particular, self-locking bandages for retention and supporting of soft tissues and fastening of dressings.SUBSTANCE: self-locking bandage comprises cloth made from mixture of various fibers or 100%-cotton with microdot latex coating. Self-locking bandage is non-allergenic and has good hygienic properties.EFFECT: simplified structure, reliable usage, and improved ecological safety of self-locking bandage.1 tbl, 3 ex

Polymeric film sheet having surfactant mixture as assitive // 2292920
FIELD: medicine.SUBSTANCE: invention relates to coat made of film with openings for absorbent article. Coat is applied with additive combination containing hydrophilic substance and lyophylic substance. Said additive combination makes it possible to improve fluid transport through coat and to reduce friction force in process of turunda production.EFFECT: improved material for medicine application.41 cl, 4 tbl
Hemostatic material // 2287333
FIELD: pharmaceutics.SUBSTANCE: the suggested hemostatic material contains collagen and thrombocytic mass dried due to freeze drying and structured in formaldehyde vapors, moreover, it contains transfusion-unsuitable thrombocytes at the following ratio: collagen : thrombocytes = 100:(0.5-2.5). Additionally, this material may contain antiseptics or antibiotics of wide spectrum of action. The innovation enables to apply thrombocytes after cryodestruction, and, also, transfusion-unsuitable thrombocytes (overdue storage period), that is apply the material which is considered to be useless. The material suggested is of high hemostatic activity.EFFECT: higher efficiency of application.11 ex

Cellulose sheet, method of production of such sheet, method of production of compacted cloth, method of modifying properties and article for absorption of aqueous fluid medium // 2266926
FIELD: cellulose fibers treated with oil and compacting agent for modifying properties of fibers; methods of production of cellulose fibers.SUBSTANCE: cellulose sheet includes: cellulose fibers, oil applied on cellulose fibers; oil is present in the amount of about 0.5 to 20 mass-% of mass of dry fibers and modifying agent applied on cellulose fibers; modifying agent is present in the amount of about 0.5 to 20 mass-% of active agents of dry mass of fibers. Method of production of cellulose sheet includes: preparation of cellulose mass, molding cellulose sheet from this mass, application of oil on cellulose sheet; oil is present on fibers in the amount of about 0.5 to 20 mass-% of mass of dry fibers and application of modifying agent on cellulose fibers; modifying agent is present in the amount of about 0.5 to 20 mass-% of active agents of dry mass of fibers. Method of production of compacted cloth of cellulose fibers includes: making cellulose fibers treated with oil and modifying agent which modifies properties of compacting the cellulose fibers; cellulose fibers treated with oil and modifying agent contain about 0.5 to 20 mass-% of active agents of dry mass of cellulose fibers; method includes also separation of cellulose fibers treated with oil and compacting modifying agent, molding separated cellulose fibers treated with oil and modifying agent into cloth and compression of cloth. Method of modifying properties for compacting of cellulose fibers includes treatment of fibers with oil; before treatment of cellulose fibers with oil and after application and removal of compressive load they are compacted to first specific mass; then cellulose fibers are compacted to second specific mass after application and removal of compressive force; first specific mass exceeds second specific mass; this method includes: application of modifying agent on fibers treated with oil; this modifying agent modifies properties of fibers for compacting; it is applied on cellulose fibers in the amount of about 0.5 to 20 mass-% of active agents of dry mass of cellulose fibers; modifying agent is applied on fibers treated with oil in the amount sufficient for compacting the fibers to third specific mass after application and removal of compressive load; third specific mass is more than first specific mass. Article for absorption of aqueous fluid medium includes: super-absorbing materials and oil applied on cellulose fibers in the amount of about 0.5 to 20 mass-% of mass of dry fibers and modifying agent applied on cellulose fibers in the amount sufficient for presence of active agents in the amount of about 0.5 to 20 mass-% of dry mass of cellulose fibers.EFFECT: possibility of retaining super-absorbing materials in structures.38 cl, 3 dwg, 1 tbl
Alkali-neutralizing superabsorption products // 2258536
FIELD: sanitary and hygienic facilities.SUBSTANCE: superabsorption product of invention comprising liquid-impermeable base layer; liquid-absorbing intermediate layer containing partially neutralized acid-behaving hydrophilic polymer, in particular surface cross-linked polyacrylate; and liquid-permeable non-absorbing top layer is distinguished by containing alkali-neutralizing additive uniformly spread in absorbing intermediate layer.EFFECT: enhanced controlling unpleasant smell and inhibited microbial growth.10 cl, 1 tbl
Product designed as cosmetic wipes // 2245706
FIELD: medicine.SUBSTANCE: the present method deals with a product designed as disposable cosmetic wipes that contain soft water-insoluble substrate such as tissue impregnated with either alpha- or beta-hydroxycarbonic acid in cosmetically acceptable carrier-foundation. Impregnating cosmetic compositions will have pH of not above 6.8 in water. Silicone microemulsion is available to minimize stickiness being the result of applying hydroxycarbonic acid upon skin with the above-suggested wipes. In the presence of surface-active substances that contain groups of fatty acid, silicone microemulsion prevents the appearance of unpleasant odors which could be produced by surface-active substance in the course of hydrolysis at low pH.EFFECT: higher efficiency of application.14 cl, 9 ex, 2 tbl

Composition for absorbing article and method for binding skin-irritating substances using this composition // 2244565
FIELD: medicine, pharmacy.SUBSTANCE: invention describes absorbing articles for individual hygiene, such as diapers and articles for adults suffering with enuresis, and methods for applying including application of absorbing article on which effective amount of substances is applied for binding skin-irritating substances. The applied agent consists of the substance with non-modified particles binding skin-irritating substances and lipophilic and favorable for skin health agent. The non-modified agent consisting of particles and binding skin-irritating substances can be represented by clay, such as bentonite or laponite. The lipophilic and favorable for skin health agent can be represented by stearic acid, isoparaffin, vaseline and their combination. Absorption of indicated skin-irritating substances allows prophylaxis for their penetration in skin wherein they can cause damage and inflammation.EFFECT: improved binding method, valuable hygienic properties of article.20 cl, 7 dwg, 3 tbl, 7 ex

Adsorbents intended for use in the processing of complex fluids // 2242250
The invention relates to the use of absorbent particles in absorbent structures and disposable absorbent products

Atraumatic dressing // 2242204
The invention relates to the production of medical devices, particularly atraumatic initially in contact with the wound funds

The method of obtaining the dressing material // 2203684
The invention relates to medicine, namely to a method for dressings for the treatment of purulent-necrotic wounds of different etiology

Hemostatic bandage // 2200583
The invention relates to medicine, specifically to dressing tools used to stop the capillary, diffuse parenchymal hemorrhage, used for closing the bleeding wounds
Absorbent medical material and products on its basis // 2197272
The invention relates to medicine, namely multilayer absorbent nonwoven haloprogin cloth and absorbent structures which can be used in personal hygiene products, such as, for example, dressing tools, bandages, compresses, etc
Treatment of ingrown nail // 2196618
The invention relates to medicine, physical therapy, and can be used to treat ingrown nail
A method of treatment of diseases of the joints // 2195977
The invention relates to medicine, physiotherapy and can be used for the treatment of diseases of the joints

The absorbent product // 2192833
The invention relates to medicine

Gel dosage form // 2191034
The invention relates to a gel-like medications intended for the treatment of injuries of the skin and superficial tissues of humans and animals

yringoplasty swab // 2182017
The invention relates to medicine, namely to otolaryngology, and may find application in chronic purulent mesotympanic

Treatment of trophic ulcers of venous origin // 2178311
The invention relates to medicine, namely to conservative methods of treatment of trophic ulcers of venous origin

A method of treating ulcers in the diabetic foot syndrome // 2178310
The invention relates to medicine, namely to the treatment of ulcers in the diabetic foot syndrome

edical device // 2171694
The invention relates to medicine and can be used in clinical medicine as a disinfectant, an antimicrobial, used as a skin antiseptic for processing surgical and injectable fields, sterilization of medical instruments
Paper with medicinal properties // 2163818
The invention relates to medicine and can be used as a therapeutic and prophylactic agent for diseases hemorrhoids

The method of obtaining the dressing material // 2149648
The invention relates to medicine and can be used for dressings for the treatment of venous ulcers

ethod of treatment of wound surfaces // 2124357
The invention relates to medicine, specifically to surgery, traumatology, in the treatment of wound surfaces
For the treatment of wounds // 2104038
The invention relates to the field of medicine, particularly to a tool for the treatment of wounds of various etiology

The method of obtaining material for the treatment of burns and purulent - necrotic wounds // 2048817
The invention relates to the bandages are used for therapeutic purposes for burns and pyo-inflammatory wounds

A method of obtaining a therapeutic agent for transdermal application // 2044541
The invention relates to medicine and relates to methods of obtaining transdermal therapeutic agents
 
2551319.
Up!